Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer.
Agus DB; Gordon MS; Taylor C; Natale RB; Karlan B; Mendelson DS; Press MF; Allison DE; Sliwkowski MX; Lieberman G; Kelsey SM; Fyfe G; Journal Of Clinical Oncology: Official Journal Of The American Society Of Clinical Oncology, 2005, vol. 23, issue 11, p 2534, ISSN 0732183x. ISBN 0732183x.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef